905P Validation of MYC/TP63 classification for adenocystic carcinomas of salivary glands
P. Economopoulou(National and Kapodistrian University of Athens), A. Psyrri(University General Hospital Attikon), Nektarios Koufopoulos(National and Kapodistrian University of Athens), Anastasios Pantazopoulos(University General Hospital Attikon), I. Kotsantis(University General Hospital Attikon), Μaria Anastasiou(National and Kapodistrian University of Athens), Aris Spathis(National and Kapodistrian University of Athens), Anastasios Kyriazoglou(Alexandra Hospital), George Kavourakis(National and Kapodistrian University of Athens), M. Moutafi(University General Hospital Attikon), I. Panayiotides(University General Hospital Attikon), Maria Kyrkasiadou(National and Kapodistrian University of Athens), Evangelos Zazas(National and Kapodistrian University of Athens), Niki Gavrielatou(National and Kapodistrian University of Athens), T Pantazopoulos(University General Hospital Attikon), Anna Boulouta(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
|Cancers|2021|58
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
|Annals of Oncology|2023|53
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
|ESMO Open|2021|48
Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling
|Journal of Thoracic Oncology|2022|40